°è¸í´ëÇб³µ¿»êº´¿ø TO the Ear of precision Oncology : 2019-10-25±³À°ÀÏÀÚ : 2019-10-25
±³À°Àå¼Ò : °è¸í´ëÇб³ µ¿»êº´¿ø 5Ãþ ¼¼¹Ì³ª½Ç1
±³À°ÁÖÁ¦ :
TO the Ear of precision OncologyÁÖÃÖ±â°ü : °è¸í´ëÇб³µ¿»êº´¿ø
´ã´çÀÚ : ¼Û¹Ì¼±
¿¬¶ôó : 053-258-6381
À̸ÞÀÏ :
cancer@dsmc.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°úÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ÀÇÇб³À°, º¸Çè
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 13:30~14:00 Update on adjuvant chemotherapy of gastric cancer Mitsuro Kanda(Nagoya University Graduate School of Medicine, Japan)
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 14:00~14:30 Organization and problems of health care or surgical treatment of cancer in Estonia Toomas Ümarik(North Estonian Medical Centre Foundation, Estonia)
Åä·Ð 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 14:30~14:50 Discussion ()
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 15:00~15:20 Oncologic imaging: Evolving images for evolving treatments Kyung Won Kim(Asan Medical Center, Korea)
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 15:20~15:40 Image analysis for RNA in situ hybridization (RNAscope) Ilseon Hwang(Keimyung University, Korea))
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 15:40~16:00 Cancer immunotherapy using phage display-identified peptides Byungheon Lee(Kyungpook National University, Korea))
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 16:00~16:20 Clinical trials: How to add translational components Yoon Ji Choi(Korea University College of Medicine, Korea))
Åä·Ð 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 16:20~16:30 Discussion ()
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 16:50~17:10 ÀÎüÀ¯·¡¹°À» ÀÌ¿ëÇÑ ¿¬±¸¿Í IRB Yong Jin Kim(Kyungpook National University, Korea))
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 17:10~17:30 ¹ÙÀÌ¿À¹ðÅ© »ùÇÃÀ» ÀÌ¿ëÇÑ ¿¬±¸°æÇè Keun Soo Ahn((Keimyung University, Korea))
±³À°½Ã°£ 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 17:30~17:50 Organoid models as a Livining Biobank Hye Won Lee((Keimyung University, Korea))
Åä·Ð 10-25 µ¿»êº´¿ø5Ãþ¼¼¹Ì³ª½Ç1 17:50~18:00 Discussion ()